ArticleFrontiers in oncology2020

The Impact on Outcome by Adding Bevacizumab to Standard Induction Chemotherapy Prior to Mesothelioma Surgery: A Retrospective Single Center Analysis.

Olivia Lauk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.